Alnylam Pharmaceuticals
ALNY
#569
Rank
$41.26 B
Marketcap
$311.14
Share price
-1.16%
Change (1 day)
27.36%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company